- CEO
- Tushar Karshanbhai Suvagiya
- Full Time Employees
- 300
- Sector
- Health services
- Industry
- Hospital/Nursing management
- Address
- Near Sun City, Vasna Bhayli Road Vadodara GU India 391410
- IPO Date
- Jun 30, 2023
- Business
- Aatmaj Healthcare Ltd. operates multidisciplinary private hospitals and clinics, providing comprehensive inpatient and outpatient healthcare services across multi-specialty and super-specialty segments. The company offers a wide range of medical services including cardiology (invasive), neurology, neurosurgery, nephrology, anesthesiology, orthopedics, neonatology, dermatology, radiology, general and laparoscopic surgery, critical care medicine, internal medicine, emergency care, ear-nose-throat, gynecology, pediatrics, joint replacement, ophthalmology, urology, cosmetic surgery, neonatal intensive care, advanced trauma care, 24-hour ambulance services, echo cardiology, TMT, and comprehensive health checkups; its facilities feature advanced infrastructure such as cardiology cath labs, tertiary care ICUs, NICUs, modular operation theaters, and diagnostic equipment including CT scans. Targeting patients, corporate employees, and institutions in the healthcare sector, the company primarily serves communities in Gujarat, India, through its network of six hospitals under brands including Jupiter Hospital (tertiary care), JTP Hospitals-Muval and JTP Hospitals-Padra (secondary care), with an aggregate bed capacity of 330 beds extendable to 430 beds.
Founded in 2014 and headquartered at Jupiter Hospital, Opp. ICAI Bhavan, Sun Pharma Atladra Road, Vadodara, Gujarat 390012, India, the company converted from a private limited entity (incorporated March 10, 2014) to a public limited company in December 2022 and listed on the NSE SME Emerge platform in July 2023. In recent developments, Aatmaj Healthcare expanded its bed capacity from 130 to 330 beds (extendable to 430) via IPO proceeds and strategic acquisitions of well-run single-doctor or multi-specialty hospitals owned by physicians aged 50+, often through low-capex lease and royalty models rather than outright purchases; this hospital chain growth initiative commenced approximately 1.5 years pre-IPO and continued into FY24. The company is pursuing further expansions including two IVF centers (allocated Rs. 4-5 crore), additional bed additions to reach 430, and long-term plans for oncology radiation units (Rs. 16 crore each), while supporting government initiatives like PMJAY for affordable care; it maintains NABH accreditation and employs 30 consultant doctors plus on-call specialists.